esorubicin has been researched along with Experimental Mammary Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Casazza, AM; Di Marco, A; Pratesi, G; Savi, G | 1 |
| Cummings, J; Marley, E; Smyth, JF; Willmott, N | 1 |
2 other study(ies) available for esorubicin and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
Antitumor activity in mice of 4'-deoxydoxorubicin in comparison with doxorubicin.
Topics: Animals; Antineoplastic Agents; Dose-Response Relationship, Drug; Doxorubicin; Female; Leukemia, Experimental; Male; Mammary Neoplasms, Experimental; Melanoma; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Sarcoma, Experimental | 1983 |
Relationship between reductive drug metabolism in tumour tissue of anthracyclines in microspherical form and anti-tumour activity.
Topics: Animals; Doxorubicin; Drug Screening Assays, Antitumor; Mammary Neoplasms, Experimental; Metabolic Clearance Rate; Microspheres; Oxidation-Reduction; Rats; Rats, Inbred Strains | 1990 |